Optimizing Management of Chronic GVHD: The Care Team’s Role in Symptom Management and Patient Care : Episode 3
Managing Severe Symptoms and Disease Progression in the GVHD Journey
Panelists discuss how chronic graft-versus-host disease typically progresses in patients requiring third-line treatment and beyond, focusing on severe symptoms, the impact on quality of life, and potential long-term consequences of inadequately managed symptoms.
Video Player is loading.
Video content above is prompted by the following:
- Can you describe the typical disease course for cGVHD patients, particularly those who progress to third-line treatment and beyond? What are some of the most severe symptoms they face?
- How does the burden of cGVHD impact a patient's quality of life, and what are some of the long-term consequences if symptoms are not properly managed?
Recent Videos
Sequencing Strategies in RCC: Optimizing Treatment Selection After IO-Based Therapy
First-Line RCC Treatment in 2025: Navigating the Evolving Therapeutic Landscape
Evolving Treatment Strategies in Early HER2+ Breast Cancer
Barbara's Story: Navigating HER2+ MBC with Brain Metastases & Tucatinib-Based Treatment in the Second-Line Setting
Bridging Communication Gaps: Comprehensive Care for Upper GI Cancer Treatment
Multidisciplinary Collaboration in Managing Treatment-Related AEs in Upper GI Cancer
Managing Symptoms and Quality of Life During HER2-Targeted Therapy for Upper GI Cancer
Patient Education Is Key to Improve Patient Adherence to Cancer Treatment
Treatment Goals, Side Effects, and Supportive Care Strategies for Patients and Caregivers with HER2+ BC
Supporting HER2+ mBC Patients in Later Lines: AE Management and the Role of the Multidisciplinary Team
Related Content
